Guardant Health: Shield Colorectal Cancer Screening To Sustain Growth

Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...
Hosted on MSN

Guardant Health announces Shield blood-based screening test results

Guardant Health (GH) “announced new real-world data published in Current Medical Research and Opinion finding that the Shield blood-based screening test demonstrates patient adherence of 95% in ...
Morningstar

Veterans' Right to Medical Choice: Shield of Odin Expands Access to Independent Medical Opinions Outside the VA System

LAS VEGAS, Jan. 5, 2026 /PRNewswire/ -- Shield of Odin today reaffirmed that veterans have the legal right to seek independent medical evaluations and opinions from licensed private healthcare ...
Seeking Alpha

Guardant Health Beats Expectations: Shield, Quest, And AI Catalysts

Guardant Health, Inc.’s Shield ADLT reimbursement, Quest, and guidance raise show good adoption momentum. These positives keep me bullish on GH stock. Their oncology business remains the revenue ...